Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving <i>reldesemtiv</i> or placebo in FORTITUDE-ALS
| Image |  |
|---|---|
| Description | scientific article published on 31 March 2023 |
| Author/s | |
| Publication date | March 31, 2023 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |